The Ratio of CD8 to Treg Tumor Infiltrating Lymphocytes Is Associated with Neoadjuvant Cisplatin Based Chemotherapy Response in Patients with Muscle Invasive Urothelial Carcinomas of the Bladder

被引：0
作者：
Baras, Alexander
Drake, Charles
Liu, Jen-Jane
Gandhi, Nilay
Kates, Max
Hoque, Mohamed
Meeker, Alan
Hahn, Noah M.
Schoenberg, Mark
Taube, Janis
Bivalacqua, Trinity J.
Netto, George J.
机构：
[1] Johns Hopkins, Baltimore, MD USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
856
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
  • [21] Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study
    Elkarta, Ahmed
    Awadalla, Amira
    El-hefnawy, Ahmed
    Mosbah, Ahmed
    Abolenein, Hassan
    Shokeir, Ahmed
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 38 - 46.e1
  • [22] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    PLOS ONE, 2016, 11 (05):
  • [23] Pathologic down-staging and complete pathologic response with gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder
    Psutka, Sarah P.
    Olumi, Aria F.
    Feldman, Adam S.
    Saylor, Philip James
    Kaufman, Donald S.
    Lee, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [24] Relationship between neutrophils/lymphocytes and tumor infiltrating lymphocytes stroma in patients with invasive muscle bladder cancer and the response to treatment.
    Eduardo Richardet, Martin
    Gimena Ferreira, Maria
    Paradelo, Martin
    Paola Acosta, Luciana
    Molina, Matias
    Magi, Ignacio
    Richardet, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
    Li, Roger
    Nocera, Luigi
    Rose, Kyle M.
    Raggi, Daniele
    Naidu, Shreyas
    Mercinelli, Chiara
    Cigliola, Antonio
    Tateo, Valentina
    Patane, Damiano
    Grass, G. Daniel
    Gilbert, Scott M.
    Sexton, Wade J.
    Bandini, Marco
    Moschini, Marco
    Briganti, Alberto
    Montorsi, Francesco
    Spiess, Philippe E.
    Necchi, Andrea
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 614 - 624
  • [26] Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
    Seah, Jo-An
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Alimohamed, Nimira
    Knox, Jennifer J.
    Joshua, Anthony M.
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : E229 - E233
  • [27] The survival impact of stromal tumor-infiltrating lymphocytes for patients with metastatic urothelial carcinoma treated with cisplatin-based chemotherapy
    Hsieh, M-C.
    Huang, H-S.
    Su, Y-L.
    Chiang, P-H.
    Huang, C-H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
    Koshkin, Vadim S.
    Barata, Pedro C.
    Rybicki, Lisa A.
    Zahoor, Haris
    Almassi, Nima
    Redden, Alicia M.
    Fergany, Amr F.
    Kaouk, Jihad
    Haber, Georges-Pascal
    Stephenson, Andrew J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Garcia, Jorge A.
    Rini, Brian, I
    Grivas, Petros
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E879 - E892
  • [29] Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer
    Rimar, Kalen J.
    Glaser, Alexander P.
    Kundu, Shilajit
    Schaeffer, Edward M.
    Meeks, Joshua
    Psutka, Sarah P.
    BLADDER CANCER, 2018, 4 (04) : 411 - 418
  • [30] Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
    Plimack, Elizabeth R.
    Dunbrack, Roland L.
    Brennan, Timothy A.
    Andrake, Mark D.
    Zhou, Yan
    Serebriiskii, Ilya G.
    Slifker, Michael
    Alpaugh, Katherine
    Dulaimi, Essel
    Palma, Norma
    Hoffman-Censits, Jean
    Bilusic, Marijo
    Wong, Yu-Ning
    Kutikov, Alexander
    Viterbo, Rosalia
    Greenberg, Richard E.
    Chen, David Y. T.
    Lallas, Costas D.
    Trabulsi, Edouard J.
    Yelensky, Roman
    McConkey, David J.
    Miller, Vincent A.
    Golemis, Erica A.
    Ross, Eric A.
    EUROPEAN UROLOGY, 2015, 68 (06) : 959 - 967
12345